Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
+8.43%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$69.1B
AUM Growth
+$6.99B
(+11%)
Cap. Flow
+$2.63B
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
21.7%
Holding
3,881
New
279
Increased
1,682
Reduced
1,438
Closed
180
Top Buys
| 1 |
Apple
AAPL
|
+$221M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
Equinix
EQIX
|
+$100M |
| 4 |
Eli Lilly
LLY
|
+$74.6M |
| 5 |
Tesla
TSLA
|
+$74.4M |
Top Sells
| 1 |
Digital Realty Trust
DLR
|
+$102M |
| 2 |
Medtronic
MDT
|
+$66.8M |
| 3 |
Charles Schwab
SCHW
|
+$55.9M |
| 4 |
American Homes 4 Rent
AMH
|
+$50.7M |
| 5 |
Prologis
PLD
|
+$48.4M |
Sector Composition
| 1 | Technology | 24.84% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 11.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Real Estate | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Leslie's
LESL
$63.3M
| $196 | ﹤0.01% |
62
-8,933
| -99% | -$28.2K |
|
3527
System1
SST
$62.2M
| $196 | ﹤0.01% |
+18
| New | +$196 |
|
3528
Sprinklr
CXM
$1.93B
| $193 | ﹤0.01% |
25
-123
| -83% | -$950 |
|
3529
EyePoint Pharmaceuticals
EYPT
$966M
| $192 | ﹤0.01% |
24
-1,043
| -98% | -$8.34K |
|
3530
Humacyte
HUMA
$223M
| $190 | ﹤0.01% |
35
-343
| -91% | -$1.86K |
|
3531
SOPHiA GENETICS
SOPH
$219M
| $190 | ﹤0.01% |
52
| – | – |
|
3532
Tyra Biosciences
TYRA
$674M
| $188 | ﹤0.01% |
8
| – | – |
|
3533
Byline Bancorp
BY
$1.35B
| $187 | ﹤0.01% |
7
-12,100
| -100% | -$323K |
|
3534
Pioneer Bancorp
PBFS
$333M
| $186 | ﹤0.01% |
+17
| New | +$186 |
|
|
TE
3535
T1 Energy Inc.
TE
$309M
| $186 | ﹤0.01% |
+192
| New | +$186 |
|
3536
Greene County Bancorp
GCBC
$407M
| $185 | ﹤0.01% |
6
| – | – |
|
3537
Clearside Biomedical
CLSD
$26.4M
| $184 | ﹤0.01% |
145
-98
| -40% | -$124 |
|
3538
Werewolf Therapeutics
HOWL
$61.7M
| $182 | ﹤0.01% |
+86
| New | +$182 |
|
3539
Fractyl Health
GUTS
$65.8M
| $180 | ﹤0.01% |
+71
| New | +$180 |
|
3540
ALX Oncology
ALXO
$59.4M
| $178 | ﹤0.01% |
98
-2,233
| -96% | -$4.06K |
|
|
AMPS
3541
DELISTED
Altus Power, Inc.
AMPS
| $175 | ﹤0.01% |
55
-7,901
| -99% | -$25.1K |
|
3542
Ultralife
ULBI
$116M
| $172 | ﹤0.01% |
+19
| New | +$172 |
|
3543
Offerpad Solutions
OPAD
$130M
| $171 | ﹤0.01% |
+42
| New | +$171 |
|
|
BOLD
3544
Boundless Bio
BOLD
$25.7M
| $170 | ﹤0.01% |
+49
| New | +$170 |
|
|
BLUE
3545
DELISTED
bluebird bio
BLUE
| $169 | ﹤0.01% |
16
-665
| -98% | -$7.02K |
|
3546
Fulcrum Therapeutics
FULC
$393M
| $168 | ﹤0.01% |
+47
| New | +$168 |
|
3547
OrthoPediatrics
KIDS
$524M
| $163 | ﹤0.01% |
+6
| New | +$163 |
|
3548
LifeMD
LFMD
$292M
| $157 | ﹤0.01% |
30
-222,878
| -100% | -$1.17M |
|
3549
Prelude Therapeutics
PRLD
$69.6M
| $157 | ﹤0.01% |
76
-1,405
| -95% | -$2.9K |
|
3550
OptimizeRx
OPRX
$340M
| $154 | ﹤0.01% |
20
-11
| -35% | -$85 |
|